Prestige Consumer Healthcare Inc
NYSE:PBH
Prestige Consumer Healthcare Inc
Free Cash Flow
Prestige Consumer Healthcare Inc
Free Cash Flow Peer Comparison
Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors
Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Prestige Consumer Healthcare Inc
NYSE:PBH
|
Free Cash Flow
$232m
|
CAGR 3-Years
4%
|
CAGR 5-Years
5%
|
CAGR 10-Years
7%
|
|
Johnson & Johnson
NYSE:JNJ
|
Free Cash Flow
$18.7B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
0%
|
CAGR 10-Years
2%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Free Cash Flow
$12.5B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
19%
|
CAGR 10-Years
12%
|
|
Pfizer Inc
NYSE:PFE
|
Free Cash Flow
$4.8B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-12%
|
|
Merck & Co Inc
NYSE:MRK
|
Free Cash Flow
$11B
|
CAGR 3-Years
18%
|
CAGR 5-Years
6%
|
CAGR 10-Years
1%
|
|
Eli Lilly and Co
NYSE:LLY
|
Free Cash Flow
-$3.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Prestige Consumer Healthcare Inc's Free Cash Flow?
Free Cash Flow
232m
USD
Based on the financial report for Dec 31, 2023, Prestige Consumer Healthcare Inc's Free Cash Flow amounts to 232m USD.
What is Prestige Consumer Healthcare Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
7%
Over the last year, the Free Cash Flow growth was 3%. The average annual Free Cash Flow growth rates for Prestige Consumer Healthcare Inc have been 4% over the past three years , 5% over the past five years , and 7% over the past ten years .